3 sources checked · 2 source groups included · 1h ago
Different Spin
FDA panel recommends m RNA flu vaccine for older adults
A first-of-its-kind flu shot is a step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s m RNA-based vaccine for approval. The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh th...
2 Left0 Center1 Right
Same story. Different framing.Left and right outlets are covering the same event. Optics is still watching for center pickup.
DIFFERENT SPIN
HOW EACH SIDE WORDED IT
Left-leaningCenter-leftFDA panel recommends m RNA flu vaccine for older adultsThe Hill HomeHigh
vs
Right-leaningNew Moderna m RNA Jab Approved By FDA Vaccine Advisory Panel100 Percent Fed UpLow
modernaapprovedadvisory
As of June 18, 2026 at 11:00 PM, this is how Optics News reads the wording differences in this story.
What happenedFDA panel recommends m RNA flu vaccine for older adults.
The headline splitThe left frames it as "FDA panel recommends m RNA flu vaccine for older adults". The right frames it as "New Moderna m RNA Jab Approved By FDA Vaccine Advisory Panel".
Match confidenceMedium confidence. 3 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
3 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
73/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftFDA panel recommends m RNA flu vaccine for older adults
The Hill Home · Center-left · News report
CenterNo matching source in this bucket yet.
Optics keeps watching for pickup.
Right / center-rightNew Moderna m RNA Jab Approved By FDA Vaccine Advisory Panel
FDA panel recommends m RNA flu vaccine for older adults
A first-of-its-kind flu shot is a step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s m RNA-based va...
FDA panel backs first-of-its-kind flu vaccine using m RNA technology
backsfirst-of-its-kindusingtechnology
A new kind of flu vaccine is moving a step closer to the U.S. market. Federal health advisers on Thursday recommended approval of a shot made with the same m RNA technology that was key to...
